Literature DB >> 22225770

Duplication of CXC chemokine genes on chromosome 4q13 in a melanoma-prone family.

Xiaohong R Yang1, Kevin Brown, Maria T Landi, Paola Ghiorzo, Celia Badenas, Mai Xu, Nicholas K Hayward, Donato Calista, Giorgio Landi, William Bruno, Giovanna Bianchi-Scarrà, Paula Aguilera, Susana Puig, Alisa M Goldstein, Margaret A Tucker.   

Abstract

Copy number variations (CNVs) have been shown to contribute substantially to disease susceptibility in several inherited diseases including cancer. We conducted a genome-wide search for CNVs in blood-derived DNA from 79 individuals (62 melanoma patients and 17 spouse controls) of 30 high-risk melanoma-prone families without known segregating mutations using genome-wide comparative genomic hybridization (CGH) tiling arrays. We identified a duplicated region on chromosome 4q13 in germline DNA of all melanoma patients in a melanoma-prone family with three affected siblings. We confirmed the duplication using quantitative PCR and a custom-made CGH array design spanning the 4q13 region. The duplicated region contains 10 genes, most of which encode CXC chemokines. Among them, CXCL1 (melanoma growth-stimulating activity α) and IL8 (interleukin 8) have been shown to stimulate melanoma growth in vitro and in vivo. Our data suggest that the alteration of CXC chemokine genes may confer susceptibility to melanoma. Published 2012. This article is a US Government work and is in the public domain in the USA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22225770      PMCID: PMC3288577          DOI: 10.1111/j.1755-148X.2012.00969.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  16 in total

1.  Induction of haptotactic migration of melanoma cells by neutrophil activating protein/interleukin-8.

Authors:  J M Wang; G Taraboletti; K Matsushima; J Van Damme; A Mantovani
Journal:  Biochem Biophys Res Commun       Date:  1990-05-31       Impact factor: 3.575

2.  The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma.

Authors:  H Haghnegahdar; J Du; D Wang; R M Strieter; M D Burdick; L B Nanney; N Cardwell; J Luan; R Shattuck-Brandt; A Richmond
Journal:  J Leukoc Biol       Date:  2000-01       Impact factor: 4.962

3.  The gene expression signatures of melanoma progression.

Authors:  Christopher Haqq; Mehdi Nosrati; Daniel Sudilovsky; Julia Crothers; Daniel Khodabakhsh; Brian L Pulliam; Scot Federman; James R Miller; Robert E Allen; Mark I Singer; Stanley P L Leong; Britt-Marie Ljung; Richard W Sagebiel; Mohammed Kashani-Sabet
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-15       Impact factor: 11.205

Review 4.  Role of CXCL1 in tumorigenesis of melanoma.

Authors:  Punita Dhawan; Ann Richmond
Journal:  J Leukoc Biol       Date:  2002-07       Impact factor: 4.962

Review 5.  Melanoma etiology: where are we?

Authors:  Margaret A Tucker; Alisa M Goldstein
Journal:  Oncogene       Date:  2003-05-19       Impact factor: 9.867

6.  Gene expression profiling of human melanoma cell lines with distinct metastatic potential identifies new progression markers.

Authors:  François Bertucci; Cécile Pages; Pascal Finetti; Philippe Rochaix; Laurence Lamant; Elizabeth Devilard; Cathy Nguyen; Rémi Houlgatte; Daniel Birnbaum; Luc Xerri; Pierre Brousset
Journal:  Anticancer Res       Date:  2007 Sep-Oct       Impact factor: 2.480

7.  Effects of MGSA/GRO alpha on melanocyte transformation.

Authors:  E Balentien; B E Mufson; R L Shattuck; R Derynck; A Richmond
Journal:  Oncogene       Date:  1991-07       Impact factor: 9.867

8.  Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells.

Authors:  J Norgauer; B Metzner; I Schraufstätter
Journal:  J Immunol       Date:  1996-02-01       Impact factor: 5.422

9.  Expression of CXCR1 and CXCR2 receptors in malignant melanoma with different metastatic potential and their role in interleukin-8 (CXCL-8)-mediated modulation of metastatic phenotype.

Authors:  Michelle L Varney; Aihua Li; Bhavana J Dave; Corazan D Bucana; Sonny L Johansson; Rakesh K Singh
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

Review 10.  The role of chemokines in melanoma tumor growth and metastasis.

Authors:  Aimee S Payne; Lynn A Cornelius
Journal:  J Invest Dermatol       Date:  2002-06       Impact factor: 8.551

View more
  4 in total

Review 1.  Update in genetic susceptibility in melanoma.

Authors:  Miriam Potrony; Celia Badenas; Paula Aguilera; Joan Anton Puig-Butille; Cristina Carrera; Josep Malvehy; Susana Puig
Journal:  Ann Transl Med       Date:  2015-09

2.  Rare Germline Copy Number Variations and Disease Susceptibility in Familial Melanoma.

Authors:  Jianxin Shi; Weiyin Zhou; Bin Zhu; Paula L Hyland; Hunter Bennett; Yanzi Xiao; Xijun Zhang; Laura S Burke; Lei Song; Chih Hao Hsu; Chunhua Yan; Qingrong Chen; Daoud Meerzaman; Casey L Dagnall; Laurie Burdette; Belynda Hicks; Neal D Freedman; Stephen J Chanock; Meredith Yeager; Margaret A Tucker; Alisa M Goldstein; Xiaohong R Yang
Journal:  J Invest Dermatol       Date:  2016-07-29       Impact factor: 8.551

3.  Application of Machine Learning to Development of Copy Number Variation-based Prediction of Cancer Risk.

Authors:  Xiaofan Ding; Shui-Ying Tsang; Siu-Kin Ng; Hong Xue
Journal:  Genomics Insights       Date:  2014-06-26

Review 4.  CXCL1: Gene, Promoter, Regulation of Expression, mRNA Stability, Regulation of Activity in the Intercellular Space.

Authors:  Jan Korbecki; Katarzyna Barczak; Izabela Gutowska; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2022-01-12       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.